FMR LLC 13D and 13G filings for Blueprint Medicines Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 2,247,679 3.500% | -2,100,632 (-48.31%) | Filing |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 4,348,311 7.153% | -324,800 (-6.95%) | Filing |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 4,673,111 7.687% | -4,301,434 (-47.93%) | Filing |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 8,974,545 14.999% | 2,941,866 (+48.77%) | Filing |
| 2022-05-10 10:13 am Purchase | 2022-05-09 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 6,032,679 10.126% | 3,684,227 (+156.88%) | Filing |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 2,348,452 3.991% | -1,841,923 (-43.96%) | Filing |
| 2021-02-08 10:17 am Sale | 2021-02-05 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 4,190,375 7.518% | -917,344 (-17.96%) | Filing |
| 2020-04-10 2:00 pm Sale | 2020-04-09 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 5,107,719 9.454% | -2,271,471 (-30.78%) | Filing |